期刊簡介 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | MICROBIOLOGY AND IMMUNOLOGY LetPub Score 5.1
50 ratings
Rate
Reputation 6.4 Influence 3.7 Speed 7.0 | ||||||||||||||||||||||||
期刊簡稱 | MICROBIOL IMMUNOL | ||||||||||||||||||||||||
ISSN | 0385-5600 | ||||||||||||||||||||||||
E-ISSN | 1348-0421 | ||||||||||||||||||||||||
h-index | 65 | ||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||
自引率 (2023-2024) | 0.00%自引率趨勢 | ||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||
官方網站 | http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1348-0421 | ||||||||||||||||||||||||
在線稿件提交 | http://mc.manuscriptcentral.com/mai | ||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||
出版商 | Wiley-Blackwell | ||||||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||||||
出版國/地區 | JAPAN | ||||||||||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||||||||||
創刊年 | 1977 | ||||||||||||||||||||||||
每年文章數 | 53每年文章數趨勢 | ||||||||||||||||||||||||
黃金OA百分比 | 10.38% | ||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q4
| ||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0385-5600%5BISSN%5D | ||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Sort of slow, 4-8 Week(s) | ||||||||||||||||||||||||
競爭力 * | 來自作者的數據: Moderate | ||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[MICROBIOLOGY AND IMMUNOLOGY] 的評論 | 撰寫評論 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 13:30:16 評論於 I love spending time with my family, we always have so much fun together(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 12:45:28 評論於 Make a list of the most important keywords; come up with a title that incorporates all the vocabulary; delete unnecessary/repeated words and link the remaining words; rewrite the title after removing non-essential information(0) 讚! | 维尔娜菲茨杰拉德 |
作者: Oswald Edie 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 23:49:53 評論於 Is there a template for writing the title of the article?(0) 讚! | Oswald Edie |
作者: Darlene Pepys 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 13:31:16 評論於 Is there a trick to writing article titles?(0) 讚! | Darlene Pepys |
作者: 雾水逸明 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-07-18 19:45:54 評論於 Submitted for seven months, revised once with additional experiment. Strict requirements, must answer experiment questions seriously to pass. Few self-citations, first reviewer raised a question, passed second review, second reviewer raised another question, third review. Journal demanded careful revision and additional cell experiments, accepted fourth review, requirement to clarify cell signaling pathways(0) 讚! | 雾水逸明 |
作者: 雾水逸明 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-07-14 21:45:52 評論於 Review speed: 6.0 | Submission acceptance rate: 25.0 Experience sharing: In the first round of review, one of the two reviewers raised 5 questions, which were addressed by the second reviewer. In the second round, the first reviewer raised 2 additional questions. In the third round, the journal requested a thorough revision and additional cell experiments. In the fourth round, a clearer cell pathway diagram was requested(0) 讚! | 雾水逸明 |
作者: 上清运浩 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-08-02 13:20:20 評論於 Is no one subscribing to this magazine?(0) 讚! | 上清运浩 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-14 19:34:49 評論於 It's a good sign that the score has increased from below 1.5 to close to 2. This magazine is worth having(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2011-06-29 22:51:22 評論於 Research focus: Microbiology; Gut microbiota(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us